The search for lab space has become increasingly expensive and competitive, with the challenge of low vacancy rates exacerbated by a river of venture capital money flowing toward startups. Biotech VC funding hit a record $43.3B last year, according to Newmark’s 2021 year-end analysis, topping 2020’s then-record $29.9B haul. With that funding closely tied to startup expansion and the signing of new leases, a number of newly flush firms are battling for new lab and office space right now. 
“Historically, there’s a high correlation around money raised and the need for expansion,” Colliers Director of Research Aaron Jodka said. “Typically, expansion happens six to nine months after a big fundraising round, sometimes sooner depending on the firm.”The type of science each startup focuses on will largely dictate the space…  Read the full story here. | 
